Accent Therapeutics upgrades to Xavo R3 for their small molecule Compound Management needs
Xavo, a leading provider of Software-as-a-Service for Biopharma R&D is pleased to announce that Accent Therapeutics has gone live with the latest...
Xavo wants to thank everybody for the great participation and interest in our Xavo R3 product! If you missed it, use the opportunity to reach out to us directly and we are happy to provide you a demonstration of our product.
Xavo, a leading provider of Software-as-a-Service for Biopharma R&D is pleased to announce that Accent Therapeutics has gone live with the latest...
Xavo, a leading provider of innovative software solutions for Life Sciences R&D, proudly announces Plexium (www.plexium.com) as its latest esteemed...
Xavo, a leading provider of Software-as-a-Service for Biopharma R&D with offices in Boston, MA, Bayreuth, Germany and Basel, Switzerland, is pleased...